tobramycin has been researched along with colistin in 196 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (8.67) | 18.7374 |
| 1990's | 39 (19.90) | 18.2507 |
| 2000's | 33 (16.84) | 29.6817 |
| 2010's | 78 (39.80) | 24.3611 |
| 2020's | 29 (14.80) | 2.80 |
| Authors | Studies |
|---|---|
| Friis, B | 1 |
| Davis, SD | 1 |
| Barry, AL; Gavan, TL; Markley, E; Matsen, JM; Norton, R; O'Brien, TF; Schoenknecht, FD; Thornsberry, C; Thrupp, LD | 1 |
| Hoogkamp-Korstanje, JA; Westerdaal, NA | 1 |
| Dessaut, B; Dulong de Rosnay, HL; Grimont, PA; Lesgouarres, MT | 1 |
| Nord, CE; Wadström, T; Wretlind, B | 1 |
| Faber-Nijholt, R; Stoutenbeek, CP; van Saene, HK; van Saene, JJ | 1 |
| Bleichrodt, RP; Manson, WL; Rosman, C; Wübbels, GH | 1 |
| Oppenheim, BA; Taylor, ME | 1 |
| Chevret, S; Delatour, F; Faurisson, F; Gastinne, H; Wolff, M | 1 |
| Antonelli, M; Cicconetti, F; Gasparetto, A; Vivino, G | 1 |
| Ahnefeld, FW; Deller, A; Graf, B; Heeg, K; Kilian, J; Konrad, F | 1 |
| Boyer, G; Darbas, H; Donadio, D; Monnet, P; Ramounau-Pigot, A | 1 |
| Diemer, W; Fegeler, W; Hartenauer, U; Kehrel, R; Lawin, P; Ritzerfeld, W; Thülig, B | 2 |
| Bachmann, P; Bui-Xuan, B; Godard, J; Guillaume, C; Motin, J; Nageotte, A; Reverdy, ME | 1 |
| Altuna-Cuesta, A; Carrillo, A; Garcia, J; León, J; López, A; Martínez-Pellús, AJ; Rodríguez-Roldán, JM | 1 |
| Mehta, DM; Panders, AK; Spijkervet, FK; van Saene, HK; van Saene, JJ; Vermey, A | 1 |
| Ahnefeld, FW; Heeg, K; Kilian, J; Konrad, F; Schwalbe, B; Wagner, H; Wiedeck, H | 1 |
| Alcock, SR; Parrott, DM; Speekenbrink, AB | 1 |
| Lerk, CF; Stoutenbeek, CP; van Saene, HK; van Saene, JJ | 1 |
| Chan, EL; Zabransky, RJ | 1 |
| Hulstaert, PF; Kerver, AJ; Mevissen-Verhage, EA; Rommes, JH; Verhoef, J; Vos, A; Wittebol, P | 1 |
| Stoutenbeek, CP; van Saene, HK; Zandstra, DF | 1 |
| Rommes, JH; van Saene, HK; van Uffelen, R | 1 |
| Cox, HU; Luther, DG | 1 |
| Arnulf, JJ; Diesnis, P; Dor, V; Gioanni, T; Jourdan, J; Kreitmann, P; Mermet, B; Schmitt, R | 1 |
| Belohradsky, BH; Marget, W; Roos, R | 1 |
| Heeckt, P; Lee, KK; Lee, TK; Rowe, MI; Schraut, WH; Smith, SD | 1 |
| Fernández-del Castillo, C; Ferraro, MJ; Foitzik, T; Mithöfer, K; Rattner, DW; Warshaw, AL | 1 |
| Hammond, JM; Potgieter, PD | 2 |
| Beaulieu, R; Dessanges, JF; Farinotti, R; Faurisson, F; Grimfeld, A; Kitzis, MD; Lefebvre, JP; Peytavin, G; Sautegeau, A | 1 |
| Boissinot, E; Diot, P; Le Pape, A; Lemarié, E | 1 |
| del Rey-Calero, J; García Gonzalez, JI; García-Magan, P; Herruzo-Cabrera, R | 1 |
| Bonten, MJ; Gaillard, CA; Johanson, WG; Smeets, HG; Stobberingh, EE; van der Geest, S; van Tiel, FH | 1 |
| Andreoni, B; Biffi, R; Gatti, S; Marini, A; Marzona, L; Matinato, C; Nicastro, G; Piazzini, A; Privitera, G; Rossi, G | 1 |
| Adair, CG; Feron, B; Gorman, SP; McClurg, B | 1 |
| Hammond, JM; Potgieter, PD; Saunders, GL | 1 |
| Adair, CG; Goldsmith, EC; Gorman, SP; McClurg, B; O'Neill, FB; Webb, CH | 1 |
| De Monte, A; Di Silvestre, A; Giordano, F; Muzzi, R; Nardi, G; Peressutti, R; Proietti, A; Troncon, MG; Valentinis, U | 1 |
| Claeys, G; Colardyn, F; De Deyne, C; de Hemptinne, B; Decruyenaere, J; Hesse, U; Hoste, E; Lutz-Dettinger, N; Vandewoude, K; Vogelaers, D | 1 |
| Behne, M; Hanisch, E; Müller, C | 1 |
| Beaulieu, R; Dessanges, JF; Farinotti, R; Faurisson, F; Grimfeld, A; Kitzis, MD; Lefevre, JP; Peytavin, G; Sautegeau, A | 1 |
| Conte, E; Gatti, S; Matinato, C; Privitera, G; Reggiani, P; Rossi, G | 1 |
| Abele-Horn, M; Bauernfeind, A; Dauber, A; Gleich, P; Ruckdeschel, G; Russwurm, W; Seyfarth-Metzger, I | 1 |
| Benzer, H; Berger, J; Javorsky, F; Lejeune, P; Lingnau, W; Mutz, N | 1 |
| Andreoni, B; Biffi, R; Conte, E; Gatti, S; Privitera, G; Rossi, G | 1 |
| Burk, M; Earle, J; Foote, RL; Frank, AR; Gulavita, S; Loprinzi, CL; Novotny, PJ; Okuno, SH; Sloan, JA | 1 |
| Chen, JS; Liang, HP; Lu, LR; Sheng, ZY; Shi, ZG; Yao, YM; Yu, Y; Zhou, BT | 1 |
| Aebischer, CC; Mordasini, C; Schoch, OD | 1 |
| Baroni, C; Bondi, E; Carrassi, A; Gatti, M; Lodi, G; Porter, SR; Prete, A | 1 |
| Bru, M; Canovas, J; Fuentes, T; Martinez-Pellús, AE; Merino, P; Moro, J; Sapiña, J; Seller, G | 1 |
| Hirner, A; Späth, G | 1 |
| Alvarado, F; Delgado, MA; Dorao, P; García, S; Goded, F; Herruzo, R; Ruza, F | 1 |
| Rommes, JH; van Saene, HK; Zandstra, DF | 1 |
| Baines, P; Hughes, J; Jones, A; Makura, Z; Morar, P; Selby, A; van Saene, R | 1 |
| Martín, M; Mateu, E | 1 |
| Geraedts, AA; Kesecioglu, J; Tytgat, GN; van der Ende, A; van der Hulst, RW; van der Voort, PH; Zandstra, DF | 1 |
| Gan-Teng, AM; Harms, ER; Hendriks, WD; Levendag, PC; Schmitz, PI; van der Est, H; Visch, LL; Wijers, OB; Wilims, EB | 1 |
| Bingen, E; Bonacorsi, S; Brahimi, N; Gérardin, M; Lebourgeois, M; Mariani-Kurkdjian, P; Munck, A; Navarro, J | 1 |
| Agustí, C; Argerich, MJ; Ariza, J; Ayats, J; Badía, M; Corbella, X; Domínguez, MA; Pujol, M | 1 |
| Schülin, T | 1 |
| Assael, BM; Candusso, M; Faraguna, D; Marchetti, F | 1 |
| Griese, M; Müller, I; Reinhardt, D | 1 |
| Elphick, H; Evans, GS; Everard, ML; Jones, A; Pettitt, E | 1 |
| Gallagher, CG; Govan, JR; Hodson, ME | 1 |
| Borel, B; Charara, O; Foucaud, P; Nathanson, S; Petitprez, P; Pin, I | 1 |
| Pitt, TL; Sparrow, M; Stefanidou, M; Warner, M | 1 |
| Gallagher, CG; Hodson, ME | 1 |
| Govan, JR | 1 |
| Ariza, J; Ayats, J; Borraz, C; Cabellos, C; Corbella, X; Doménech, A; Gudiol, F; Montero, A; Tubau, F | 1 |
| Alvarez, A; Baquero, F; Cantón, R; Cobos, N; de Gracia, J; García-Quetglas, E; Gartner, S; Honorato, J; Oliver, A; Salcedo, A | 1 |
| Darbas, H; Diego, I; Gouby, A; Jean-Pierre, H; Jeannot, JL; Jumas-Bilak, E; Marchandin, H; Teyssier, C | 1 |
| Kamin, W; Krämer, I; Schwabe, A | 1 |
| Ben Nsira, S; Dupuis, M; Leclercq, R | 1 |
| Adam, HJ; Laing, N; Mayer, M; Zhanel, GG | 1 |
| Adeboyeku, D; Hodson, ME; Scott, S | 1 |
| Bosomworth, M; Clifton, I; Conway, SP; Etherington, C; Peckham, DG | 1 |
| Heininger, A; Krueger, WA; Marschal, M; Meyer, E; Schwab, F; Unertl, K | 1 |
| Bulut, T; Dongelmans, DA; Korevaar, JC; Schultz, MJ; Spronk, PE; Veelo, DP | 1 |
| Konstan, MW; Mabie, JA; Mayer-Hamblett, N; Mink, DR; Moskowitz, SM; Pasta, DJ; Silva, SJ; Wagener, JS | 1 |
| Ciznár, I; Hostacká, A | 1 |
| Brion, F; Chaminade, P; Chaumeil, JC; Clarot, I; Esposito, S; Nicolas, A; Rieutord, A; Storme-Paris, I | 1 |
| Bamford, C; Cohen, K; Gounden, R; Maartens, G; van Zyl-Smit, R | 1 |
| Chaminade, P; Clarot, I; Estevenon, O; Nicolas, A; Rieutord, A; Storme-Paris, I | 1 |
| Bertram, C; Elborn, JS; Hodson, M | 1 |
| Boni, V; Braccini, G; Braggion, C; Campana, S; Festini, F; Galici, V; Neri, AS; Taccetti, G; Trevisan, F; Zavataro, L | 1 |
| Boucher, BA; Croce, MA; Czosnowski, QA; Fabian, TC; Magnotti, LJ; Swanson, JM; Wood, GC | 1 |
| Cavanagh, J; Huigens, RW; Melander, C; Rogers, SA | 1 |
| Cacciarelli, TV; Muder, RR; Shields, RK; Singh, N; Sun, HY | 1 |
| Griese, M; Hector, A; Kappler, M | 1 |
| Abele-Horn, M; Frosch, M; Hebestreit, H; Horn, S; Oesterlein, A; Radike, K; Schoen, C; Valenza, G | 1 |
| Döring, G; Herrmann, G; Høiby, N; Molin, S; Riethmüller, J; Song, Z; Ulrich, M; Wang, H; Wu, H; Yang, L | 1 |
| Berlana, D; Jódar, R; Llop, JM; Manresa, F | 1 |
| Cho, E; Davidson, AG; Lillquist, YP | 1 |
| Pacheco, SM; Patel, JA; Postelnick, M; Sutton, S | 1 |
| Bonten, MJ; de Smet, AM; Kluytmans, JA; Melsen, WG | 1 |
| Alhede, M; Allesen-Holm, M; Bjarnsholt, T; Christensen, LD; Givskov, M; Høiby, N; Jensen, PØ; Kragh, KN; Molin, S; Nielsen, AK; Parsek, M; Qvortrup, K; Tolker-Nielsen, T; van Gennip, M; Wozniak, D | 1 |
| Bozkurt-Guzel, C; Gerceker, AA; Savage, PB | 1 |
| Arnold, HM; Kollef, MH; Sawyer, AM | 1 |
| Bianchini, E; Buzzetti, R; Campana, S; Cariani, L; Costantini, D; Taccetti, G; Trevisan, F; Zavataro, L | 1 |
| Fillaus, J; Florescu, DF; Florescu, MC; Lyden, E; Murphy, PJ | 1 |
| Angyalosi, G; Balp, MM; Capkun-Niggli, G; Doering, G; Higashi, K; Jansen, JP; Littlewood, KJ; Tiddens, HA | 1 |
| Boulanger, L; De Boeck, K; Proesmans, M; Verhaegen, J; Vermeulen, F | 1 |
| Moore, ME; Mueller, EW | 1 |
| Bai, N; Cai, Y; Kan, Q; Liang, B; Nie, X; Wang, R; Yang, J | 1 |
| Döring, G; Goldman, MH; Haliburn, C; Schuster, A | 1 |
| Calero, C; Dapena, FJ; Lopez-Campos, JL; Quintana-Gallego, E | 1 |
| Cantón, R; Girón, RM; Lamas, A; Máiz, L; Mensa, J; Olveira, C; Pastor, D; Quintana, E | 1 |
| Al Naiemi, N; Halaby, T; Kluytmans, J; van der Palen, J; Vandenbroucke-Grauls, CM | 2 |
| Daniels, T; Mills, N; Whitaker, P | 1 |
| Bahador, A; Hashemizadeh, Z; Mansoori, N; Pourakbari, B; Raoofian, R; Rostami, H; Taheri, M | 1 |
| Bonten, MJ; de Smet, AM; Oostdijk, EA | 1 |
| Damjanova, I; Kádár, B; Kocsis, B; Kristóf, K; Nagy, K; Szabó, D; Szász, M; Tóth, Á | 1 |
| Chambers, JR; Sauer, K | 1 |
| Kamin, W; Krämer, I; Wollstadt, A | 1 |
| Cantrell, A; Carroll, C; Harnan, S; Mildred, M; Tappenden, P; Uttley, L | 1 |
| Brownlee, K; Cantrell, A; Harnan, S; Tappenden, P; Taylor, C; Uttley, L; Walshaw, M | 1 |
| Brownlee, K; Harnan, S; Mildred, M; Tappenden, P; Taylor, C; Uttley, L; Walshaw, M | 1 |
| de la Cal, MA; Rommes, JH; Silvestri, L; Taylor, N; van Saene, HK; Zandstra, DF | 1 |
| Clark, P; Knight, H; Nolan, K | 1 |
| Baek, JY; Cho, SY; Chung, DR; Kang, CI; Kim, J; Kim, SH; Ko, KS; Peck, KR; Song, JH | 1 |
| Steinkamp, G | 1 |
| Goss, CH; Quon, BS; Ramsey, BW | 1 |
| Abis, GS; Bonjer, HJ; Oosterling, SJ; Stockmann, HB; van der Bij, GJ; van Egmond, M; Vandenbroucke-Grauls, CM | 1 |
| Grabein, B; Heininger, A; Krueger, WA; Sánchez-García, M; Unertl, K | 1 |
| Al Naiemi, N; Halaby, T; Vandenbroucke-Grauls, CM | 1 |
| Fiel, SB | 1 |
| Berkhout, MC; de Kok, BM; Fokkens, WJ; Heijerman, HG; Touw, DJ; van Velzen, AJ | 1 |
| Bode-Böger, SM; Kirchner, R; Knobloch, JK; Krajewski, J; Martens-Lobenhoffer, J; Mittelstädt, H; Mulrooney, T; Russlies, M; Tröger, U | 1 |
| Tappenden, P; Uttley, L | 1 |
| Bos, AC; Devadason, S; Janssens, HM; Mouton, JW; Tiddens, HA | 1 |
| Buyck, JM; Tulkens, PM; Van Bambeke, F | 1 |
| Langton Hewer, SC; Smyth, AR | 2 |
| Dasenbrook, EC; Konstan, MW; VanDevanter, DR | 1 |
| Mataraci-Kara, E; Ozbek Celik, B; Yilmaz, M | 1 |
| Cooper, R; Howe, R; Jenkins, R; Wootton, M | 1 |
| Bai, X; Gao, F; Gong, Y; Han, J; Hu, D; Li, J; Xu, J; Xu, M; Yang, X; Zhang, X; Zhu, H; Zhu, L | 1 |
| Byrne, J; Fassauer, G; Frontini, R; Gerecke, H; Jira, T; Pfeifer, C; Reinhardt, R; Remane, Y | 1 |
| Bonten, MJ; de Smet, AM; Oostdijk, EA; Wittekamp, BH | 1 |
| Bielecki, P; Gocht, B; Häussler, S; Kasnitz, N; Komor, U; Moter, A; Pawar, V; Pils, MC; Rohde, M; Weiss, S | 1 |
| Boiano, JM; Steege, AL; Sweeney, MH; Tsai, RJ | 1 |
| Blaskovich, MA; Butler, MS; Cooper, MA; Elliott, AG; Huang, JX; Kavanagh, A; Montgomery, AB; Pelingon, R; Ramu, S | 1 |
| Beaudoin, T; LiPuma, JJ; Tom, SK; Waters, V; Yau, YC | 1 |
| Baziard, G; El Hage, S; Furiga, A; Lajoie, B; Roques, C | 1 |
| Graepler-Mainka, U; Hellwig, D; Herrmann, G; Heuer, HE; Heyder, S; Kinder, B; Köster, H; Kröger, K; Melichar, VO; Mellies, U; Paul, K; Poplawska, K; Riethmüller, J; Smaczny, C | 1 |
| Adibhesami, H; Aliramezani, A; Boroumand, MA; Douraghi, M; Ghourchian, S; Jasemi, S; Mohammadzadeh, M; Rahbar, M; Zeraati, H | 1 |
| Monogue, ML; Nicolau, DP | 1 |
| Coenye, T; Crabbé, A; Davis, R; De La Fuente-Nùñez, C; Hancock, RE; Ledesma, MA; Liu, Y; Matthijs, N; Nickerson, CA; Rigole, P; Sarker, S; Van Houdt, R | 1 |
| Cao, W; Debonnett, L; Greenwood, J; Hamed, K; Mastoridis, P; Nash, EF; Schwarz, C; Sommerwerck, U; Tamm, M | 1 |
| Albada, B; Metzler-Nolte, N | 1 |
| Chambers, JR; Cherny, KE; Sauer, K | 1 |
| Crolla, RMPH; Ermens, AAM; Kluytmans, JAJW; Kluytmans-van den Bergh, MFQ; Mulder, T; Romme, J; Van't Veer, NE | 1 |
| Bonten, MJM; de Smet, AMGA; Kluytmans, JAJW; Kluytmans-van den Bergh, MFQ; Mulder, T; Nikolakopoulos, S; Roos, D; van 't Veer, NE | 1 |
| Bayjanov, JR; Bonten, MJM; Dautzenberg, MJD; Fluit, AC; Gelinck, LBS; Jansen, CL; Leverstein-van Hall, MA; Leyten, EMS; Muller, AE; Ruys, T; Scharringa, J; van der Starre, RE | 1 |
| Artiles-Campelo, F; Cabrera-Santana, M; Caipe-Balcázar, L; Hernández-Viera, MA; Hípola-Escalada, S; Lübbe-Vázquez, CF; Ruiz-Santana, S; Saavedra, P; Sánchez-Ramírez, C; Sangil-Monroy, N | 1 |
| Börger, C; Braun, A; Häussler, S; Hittinger, M; Lehr, CM; Müller, L; Murgia, X; Schwarzkopf, K; Sewald, K; Siebenbürger, L; Wronski, S | 1 |
| Garcia-Contreras, L; Hickey, AJ; Kukut Hatipoglu, M | 1 |
| Britton, WJ; Chan, HK; Chang, RYK; Kutter, E; Lin, Y; Morales, S | 1 |
| Crolla, RMPH; Kluytmans, JAJW; Kluytmans-van den Bergh, MFQ; Mulder, T; Romme, J; van der Schelling, GP; van Mourik, MSM | 1 |
| Bähre, H; Felgner, S; Häussler, S; Müsken, M; Pawar, V; Schwebs, T; Weiss, S | 1 |
| Busscher, HJ; de Jong, ED; Rozenbaum, RT; Sharma, PK; van der Mei, HC; Woudstra, W | 1 |
| Cogen, JD; Goss, CH; Nichols, DP; Nick, JA; Nick, SE; Russell, R; Saavedra, MT; Somayaji, R; Taylor-Cousar, JL | 1 |
| Bonten, MJM; Bruijning-Verhagen, PC; de Smet, AMGA; de Wit, GA; Oostdijk, EAN; Plantinga, NL; van Hout, D; van Werkhoven, CH | 1 |
| Bragonzi, A; Cigana, C; De Fino, I; Melessike, M; Ranucci, S; Rossi, A | 1 |
| Ataei, B; Farsaei, S; Gudarzi, M; Hakamifard, A; Khorvash, F; Mohajeri, F; Yaghoubi, S | 1 |
| Fatemi-Nasab, ZS; Hadadi-Fishani, M; Khaledi, A | 1 |
| Cash, KJ; David, AA; Harris, JK; Jewell, MP; Saccomano, SC; Zemanick, ET | 1 |
| Istanbullu Tosun, A; Mataraci Kara, E; Özbek Çelik, B; Yilmaz, M | 1 |
| Bathoorn, E; Bonten, M; Brandt, A; de Smet, AM; de Vos Tot Nederveen Cappel, R; Kluytmans, J; Kluytmans-van den Bergh, M; Mulder, T; Nikolakopoulos, S; Roos, D; Smits, A; van 't Veer, N; van der Vorm, E; van Etten, B; Veenemans, J; Verheijen, P; Vlaminckx, B; Vos, M; Weersink, A | 1 |
| Archetti, M; Baumgartner, M; Kümmerli, R; Mignot, I; Rezzoagli, C | 1 |
| Autry, EB; Beckman, EJ; Gardner, BM; Kuhn, RJ; Saad, A; Schadler, A; Studtmann, AE; Wurth, MA; Young, MR | 1 |
| Braeckmans, K; Coenye, T; Kaever, V; Sass, A; Teirlinck, E; Van Nieuwerburgh, F; Wille, J | 1 |
| Andrén, PE; Aranzana-Climent, V; Becker, K; Böttger, EC; Cao, S; Friberg, LE; Haldimann, K; Hobbie, SN; Hughes, D; Nilsson, A; Platzack, B; Shariatgorji, R | 1 |
| Bradbury, P; Kassiou, M; Ong, HX; Pozzoli, M; Reekie, TA; Robinson, PD; Sheikh, Z; Traini, D; Young, PM | 1 |
| Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E | 1 |
| Blau, H; Kadosh, D; Kalamaro, V; Landau, E; Mantin, H; Mei-Zahav, M; Mussaffi, H; Prais, D; Quittner, A; Taizi, T | 1 |
| Haines, RR; Hammer, KA; Putsathit, P; Tai, AS | 1 |
| Chbani, A; El Garah, F; Latapie, L; Rima, M; Roques, C; Trognon, J | 1 |
| Crass, RL; Fitzgerald, LJ; Han, MK; Jia, S; Lenhan, BE; Lipp, MA; Patel, TS; Simon, RH | 1 |
| Ardebili, A; Bagheri, H; Goharrizi, MASB; Hjimohammadi, A; Izanloo, A; Jamali, A; Shahri, FN | 1 |
| Abulaila, A; Aktas, Z; Cantón, R; Díez-Aguilar, M; Erdem, F; Kayacan, C; Morosini, MI; Oksuz, L; Oncul, O | 1 |
| Ahmed, MU; Azad, MAK; Bhujbal, SV; Li, J; Park, H; Pathak, V; Zemlyanov, D; Zhou, QT | 1 |
| Ashley, EA; Becker, K; Gysin, M; Haldimann, K; Hinfonthong, P; Hobbie, SN; Hon, PY; Hopkins, J; Kaewphanderm, N; Kesteman, T; Ling, CL; Nguyen, TH; Pham, TD; Roberts, T; Sengduangphachanh, A; Simmalavong, M; Simpson, AJH; Tan, P; Tran, HH; Turner, P; van Doorn, HR; Vasoo, S | 1 |
| Baccaro, M; Bakker, W; Murali, A; Rietjens, IMCM; van Ravenzwaay, B; Wang, J; Zhang, N; Zheng, W | 1 |
| Friman, VP; Law, JP; Wood, AJ | 1 |
| Abbasi, S; Ataei, B; Hakamifard, A; Homayouni, A; Khorvash, F; Torfeh Esfahani, AA | 1 |
| Cameron, HJ; Driemert, P; Funk-Weyer, D; Giri, V; Haake, V; Kamp, H; Murali, A; Rietjens, IMCM; Sperber, S; Sturla, SJ; Ternes, P; van Ravenzwaay, B; Zickgraf, FM | 1 |
| Dumke, M; Hafkemeyer, S; Hammermann, J; Naehrig, S; Naehrlich, L; Schulte-Hubbert, B; Sieber, S | 1 |
| Dinh, HC; Ho, DS; Ho, DT; Le, TD; Ngo, HT; Nguyen, CD | 1 |
| Alisoltani, A; Atassi, G; Hauser, AR; Medernach, R; Murphy, KR; Murphy-Belcaster, M; Nozick, S; Ozer, EA; Rhodes, NJ; Scheetz, M | 1 |
| Langton Hewer, SC; Rowbotham, NJ; Smith, S; Smyth, AR; Yule, A | 1 |
| Aktas, Z; Boral, O; Issever, H; Oksuz, L; Oncul, O; Sonmez, N | 1 |
22 review(s) available for tobramycin and colistin
| Article | Year |
|---|---|
[Inhalational antibiotic therapy in patients with cystic fibrosis and Pseudomonas infection].
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchitis; Colistin; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Pseudomonas Infections; Tobramycin | 1997 |
[Selective decontamination of the digestive tract reduces mortality in intensive care patients].
Topics: Amphotericin B; Bacterial Infections; Cefotaxime; Clinical Protocols; Colistin; Critical Care; Critical Illness; Cross Infection; Decontamination; Digestive System; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Survival Rate; Tobramycin | 1999 |
[Anti-Pseudomonas aerosol therapy in cystic fibrosis: improvement with tobramycin].
Topics: Administration, Inhalation; Adolescent; Aerosols; Anti-Bacterial Agents; Carbenicillin; Child; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Gentamicins; Humans; Nebulizers and Vaporizers; Penicillins; Placebos; Polymyxins; Pseudomonas Infections; Randomized Controlled Trials as Topic; Time Factors; Tobramycin | 2002 |
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchopneumonia; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Inhalation; Injections, Intravenous; Lung Diseases; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2005 |
Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.
Topics: Acetylcysteine; Administration, Inhalation; Albuterol; Anti-Asthmatic Agents; Anti-Bacterial Agents; Asthma; Bronchodilator Agents; Budesonide; Colistin; Cromolyn Sodium; Cystic Fibrosis; Deoxyribonuclease I; Drug Therapy, Combination; Expectorants; Humans; Ipratropium; Nebulizers and Vaporizers; Respiratory Therapy; Tobramycin | 2006 |
A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Load; Bayes Theorem; Biological Availability; Chronic Disease; Colistin; Cystic Fibrosis; Disease Progression; Female; Forced Expiratory Volume; Humans; Information Services; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Tobramycin; Treatment Outcome | 2012 |
Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Aztreonam; Chronic Disease; Colistin; Cystic Fibrosis; Humans; Lung Diseases; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Tobramycin | 2013 |
Nebuliser systems for drug delivery in cystic fibrosis.
Topics: Aerosols; Albuterol; Anti-Bacterial Agents; Bronchodilator Agents; Carbenicillin; Colistin; Cromolyn Sodium; Cystic Fibrosis; Deoxyribonuclease I; Drug Delivery Systems; Humans; Medication Adherence; Nebulizers and Vaporizers; Randomized Controlled Trials as Topic; Recombinant Proteins; Saline Solution, Hypertonic; Tobramycin | 2013 |
Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model.
Topics: Administration, Inhalation; Child; Colistin; Cost-Benefit Analysis; Cystic Fibrosis; Disease Progression; Humans; Outcome Assessment, Health Care; Pseudomonas aeruginosa; Pseudomonas Infections; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Therapeutic Equivalency; Tobramycin; United Kingdom | 2013 |
Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Disease Progression; Dry Powder Inhalers; Evidence-Based Medicine; Forced Expiratory Volume; Humans; Lung; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Research Design; Time Factors; Tobramycin; Treatment Outcome | 2013 |
[Dry powder inhalers in cystic fibrosis].
Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Diuretics, Osmotic; Drug Compounding; Dry Powder Inhalers; Humans; Mannitol; Powders; Pseudomonas Infections; Tobramycin | 2014 |
Inhaled antibiotics for lower airway infections.
Topics: Administration, Inhalation; Amikacin; Amphotericin B; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Colistin; Cystic Fibrosis; Gentamicins; Humans; Nebulizers and Vaporizers; Respiratory Tract Infections; Tobramycin | 2014 |
Aerosolized antibiotics in cystic fibrosis: an update.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Aztreonam; Colistin; Cystic Fibrosis; Equipment Design; Humans; Levofloxacin; Nebulizers and Vaporizers; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Tobramycin | 2014 |
Dry powder inhalers in cystic fibrosis: same old drugs but different benefits?
Topics: Administration, Inhalation; Anti-Bacterial Agents; Colistin; Cost-Benefit Analysis; Cystic Fibrosis; Dry Powder Inhalers; Humans; Medication Adherence; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2014 |
Inhaled antibiotics: dry or wet?
Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Aztreonam; Colistin; Cystic Fibrosis; Disease Progression; Dry Powder Inhalers; Humans; Nebulizers and Vaporizers; Pseudomonas aeruginosa; Tobramycin | 2014 |
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Topics: Administration, Inhalation; Administration, Oral; Adult; Anti-Bacterial Agents; Child; Ciprofloxacin; Colistin; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Tobramycin | 2014 |
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Topics: Administration, Inhalation; Administration, Oral; Adult; Anti-Bacterial Agents; Child; Ciprofloxacin; Colistin; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory System; Tobramycin | 2017 |
Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs.
Topics: Administration, Inhalation; Aerosols; Animals; Anti-Bacterial Agents; Biological Availability; Colistin; Drug Compounding; Dry Powder Inhalers; Humans; Lung; Models, Biological; Powders; Tobramycin | 2018 |
Cost-effectiveness of selective digestive decontamination (SDD) versus selective oropharyngeal decontamination (SOD) in intensive care units with low levels of antimicrobial resistance: an individual patient data meta-analysis.
Topics: Administration, Topical; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Carrier State; Cephalosporins; Colistin; Cost-Benefit Analysis; Cross Infection; Decontamination; Drug Resistance, Microbial; Female; Gastrointestinal Tract; Health Care Costs; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Netherlands; Oropharynx; Randomized Controlled Trials as Topic; Tobramycin | 2019 |
Correlation between biofilm formation and antibiotic resistance in Pseudomonas aeruginosa: a meta-analysis.
Topics: Anti-Bacterial Agents; Biofilms; Ceftriaxone; Colistin; Drug Resistance, Bacterial; Humans; Iran; Polymyxin B; Pseudomonas aeruginosa; Tobramycin | 2020 |
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin | 2021 |
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftazidime; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Humans; Infant; Monobactams; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2023 |
39 trial(s) available for tobramycin and colistin
| Article | Year |
|---|---|
A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group on Selective Decontamination of the Digestive Tract.
Topics: Administration, Topical; Amphotericin B; Anti-Bacterial Agents; Colistin; Critical Care; Cross Infection; Digestive System; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Pneumonia; Respiration, Artificial; Survival Rate; Time Factors; Tobramycin | 1992 |
[Pneumonia prevention in long-term mechanically ventilated patients: selective skin decontamination according to Stoutenbeek or prevention of colonization according to Unertl? A prospective randomized comparison of both treatments].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Colistin; Critical Care; Female; Gentamicins; Humans; Male; Middle Aged; Pneumonia; Polymyxin B; Prospective Studies; Respiration, Artificial; Time Factors; Tobramycin | 1991 |
[Prevention of septicemia caused by gastrointestinal tract organisms in patients with granulopenia. Comparison of three gastrointestinal tract decontamination treatments].
Topics: Agranulocytosis; Colistin; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Nystatin; Sepsis; Tobramycin; Vancomycin | 1991 |
Effect of selective flora suppression on colonization, infection, and mortality in critically ill patients: a one-year, prospective consecutive study.
Topics: Administration, Oral; Adult; Aged; Amphotericin B; Bacterial Infections; Bronchopneumonia; Colistin; Critical Care; Cross Infection; Female; Gram-Negative Aerobic Bacteria; Humans; Intensive Care Units; Male; Middle Aged; Mortality; Mouth; Ointments; Prospective Studies; Sepsis; Suspensions; Tobramycin; Urinary Tract Infections | 1991 |
Intestinal decontamination in a polyvalent ICU. A double-blind study.
Topics: Amphotericin B; Clinical Protocols; Colistin; Cross Infection; Double-Blind Method; Female; Humans; Intensive Care Units; Intestinal Diseases; Length of Stay; Male; Middle Aged; Pneumonia; Prospective Studies; Tobramycin | 1990 |
Prevention of nosocomial lung infection in ventilated patients: use of an antimicrobial pharyngeal nonabsorbable paste.
Topics: Administration, Topical; Adolescent; Adult; Aged; Amphotericin B; Child; Colistin; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Oropharynx; Prospective Studies; Respiration, Artificial; Respiratory Tract Infections; Tobramycin | 1990 |
Mucositis prevention by selective elimination of oral flora in irradiated head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Candidiasis, Oral; Colistin; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mouth; Prospective Studies; Radiotherapy; Radiotherapy Dosage; Stomatitis; Tobramycin | 1990 |
[Selective flora suppression for control of infection in surgical intensive care medicine].
Topics: Adult; Aged; Amphotericin B; Bacterial Infections; Bronchopneumonia; Clinical Trials as Topic; Colistin; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Prospective Studies; Risk Factors; Sepsis; Surgical Wound Infection; Tobramycin; Urinary Tract Infections | 1989 |
Prevention of colonization and infection in critically ill patients: a prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Bacteria; Cefotaxime; Child; Colistin; Cross Infection; Digestive System; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Oropharynx; Prospective Studies; Pseudomonas Infections; Random Allocation; Respiratory System; Tobramycin | 1988 |
Long-term effects of selective decontamination on antimicrobial resistance.
Topics: Adult; Amphotericin B; APACHE; Bacteria; Cefotaxime; Colistin; Cross Infection; Digestive System; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Prospective Studies; Respiration, Artificial; Tobramycin | 1995 |
Is there a role for selective decontamination of the digestive tract in primarily infected patients in the ICU?
Topics: Administration, Oral; Adult; Amphotericin B; Cefotaxime; Colistin; Critical Care; Critical Illness; Cross Infection; Digestive System; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Placebos; Prospective Studies; Respiration, Artificial; Survival Rate; Tobramycin | 1995 |
Colonization in patients receiving and not receiving topical antimicrobial prophylaxis.
Topics: Administration, Topical; Aged; Amphotericin B; Colistin; Colony Count, Microbial; Cross Infection; Drug Therapy, Combination; Enterobacteriaceae; Female; Humans; Intensive Care Units; Male; Middle Aged; Oropharynx; Prospective Studies; Pseudomonadaceae; Respiratory Tract Infections; Tobramycin; Trachea | 1994 |
Selective decontamination of the digestive tract in multiple trauma patients--is there a role? Results of a prospective, double-blind, randomized trial.
Topics: Adult; Amphotericin B; Bacterial Infections; Colistin; Double-Blind Method; Gastrointestinal Diseases; Humans; Injury Severity Score; Intensive Care Units; Intubation, Intratracheal; Length of Stay; Multiple Trauma; Prospective Studies; Tobramycin | 1994 |
Combined use of fluconazole and selective digestive decontamination in the prevention of fungal infection after adult liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Colistin; Digestive System; Drug Therapy, Combination; Fluconazole; Humans; Liver Transplantation; Middle Aged; Mycoses; Retrospective Studies; Risk Factors; Sputum; Tobramycin | 1995 |
[Use of selective intestinal decontamination with non-absorbable antibiotics].
Topics: Administration, Oral; Amphotericin B; Anti-Bacterial Agents; Colistin; Cross Infection; Double-Blind Method; Gastroenteritis; Humans; Intestinal Mucosa; Tobramycin | 1995 |
Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD).
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Colistin; Cross Infection; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Oropharynx; Pneumonia; Respiration, Artificial; Tobramycin | 1997 |
Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Translocation; Ciprofloxacin; Colistin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intestines; Male; Multiple Trauma; Pneumonia; Prospective Studies; Respiration, Artificial; Tobramycin | 1997 |
A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis.
Topics: Aged; Amphotericin B; Anti-Infective Agents, Local; Chlorhexidine; Colistin; Double-Blind Method; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Intestinal Absorption; Male; Middle Aged; Mouth Mucosa; Radiation Injuries; Stomatitis; Tobramycin | 1997 |
Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bone marrow transplantation.
Topics: Adolescent; Aluminum Hydroxide; Amphotericin B; Antineoplastic Agents; Bone Marrow Transplantation; Child; Child, Preschool; Colistin; Diphenhydramine; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Lidocaine; Magnesium Hydroxide; Mouth Mucosa; Stomatitis; Tobramycin; Transplantation Conditioning | 1997 |
Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass. Role of type of flow and protective effect of selective digestive decontamination.
Topics: Amphotericin B; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiopulmonary Bypass; Colistin; Cytokines; Endotoxemia; Enterobacteriaceae; Female; Humans; Intestinal Diseases; Intestines; Ischemia; Male; Middle Aged; Prospective Studies; Surgical Procedures, Operative; Tobramycin | 1997 |
Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination.
Topics: Adolescent; Antibiotic Prophylaxis; Child; Child, Preschool; Colistin; Cross Infection; Digestive System; Drug Therapy, Combination; Female; Hexetidine; Humans; Infant; Intensive Care Units, Pediatric; Male; Multiple Organ Failure; Multivariate Analysis; Nystatin; Prospective Studies; Regression Analysis; Respiratory Tract Infections; Severity of Illness Index; Tobramycin; Urinary Tract Infections | 1998 |
Gut decontamination of critically ill patients reduces Helicobacter pylori acquisition by intensive care nurses.
Topics: Adult; Amphotericin B; Breath Tests; Colistin; Critical Care; Critical Illness; Cross Infection; Cross-Sectional Studies; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Nursing Staff, Hospital; Prevalence; Stomach Diseases; Tobramycin | 2001 |
Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study.
Topics: Adult; Aged; Amphotericin B; Colistin; Double-Blind Method; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mouth Mucosa; Placebos; Radiation Injuries; Salivary Glands; Stomatitis; Tobramycin | 2001 |
Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Case-Control Studies; Ceftazidime; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Infant; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2002 |
A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Anti-Bacterial Agents; Child; Chronic Disease; Colistin; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2002 |
Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Chronic Disease; Colistin; Cross-Over Studies; Cystic Fibrosis; Female; Follow-Up Studies; Humans; Male; Pseudomonas Infections; Tobramycin | 2006 |
Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
Topics: Administration, Inhalation; Adult; Animals; Anti-Bacterial Agents; Biofilms; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Lung; Male; Microbial Sensitivity Tests; Pilot Projects; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Lew; Tobramycin; Treatment Outcome | 2010 |
Selective decontamination of the oral and digestive tract in surgical versus non-surgical patients in intensive care in a cluster-randomized trial.
Topics: Administration, Oral; Amphotericin B; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cefotaxime; Cluster Analysis; Colistin; Critical Care; Cross Infection; Decontamination; Digestive System Diseases; Drug Combinations; Female; Hospital Mortality; Humans; Infusions, Intravenous; Intubation, Gastrointestinal; Length of Stay; Male; Middle Aged; Oropharynx; Pharyngeal Diseases; Respiration, Artificial; Tobramycin | 2012 |
Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols.
Topics: Administration, Inhalation; Administration, Oral; Anti-Bacterial Agents; Chi-Square Distribution; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Infant; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Stenotrophomonas maltophilia; Tobramycin; Treatment Outcome | 2012 |
Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Infant; Male; Prospective Studies; Pseudomonas Infections; Sputum; Tobramycin; Treatment Outcome | 2013 |
Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Colistin; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Male; Powders; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome; Young Adult | 2013 |
[Nebulized colistin versus tobramycin in the treatment of chronic Pseudomonas colonization in cystic fibrosis patients].
Topics: Administration, Inhalation; Body Mass Index; Child; Child, Preschool; Colistin; Cross-Over Studies; Cystic Fibrosis; Drug Resistance, Bacterial; Female; Forced Expiratory Volume; Humans; Lung; Male; Nebulizers and Vaporizers; Patient Satisfaction; Pseudomonas aeruginosa; Sputum; Surveys and Questionnaires; Tobramycin; Treatment Outcome | 2014 |
Effects of decontamination of the digestive tract and oropharynx in intensive care unit patients on 1-year survival.
Topics: Administration, Intravenous; Aged; Amphotericin B; Anti-Bacterial Agents; Cefotaxime; Cluster Analysis; Colistin; Critical Care; Cross Infection; Cross-Over Studies; Decontamination; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Tract; Hospital Mortality; Humans; Intensive Care Units; Intubation, Gastrointestinal; Male; Middle Aged; Netherlands; Odds Ratio; Oropharynx; Primary Prevention; Survival Analysis; Tobramycin; Treatment Outcome | 2013 |
Perioperative selective decontamination of the digestive tract and standard antibiotic prophylaxis versus standard antibiotic prophylaxis alone in elective colorectal cancer patients.
Topics: Amphotericin B; Anastomotic Leak; Anti-Bacterial Agents; Antibiotic Prophylaxis; Colistin; Colorectal Neoplasms; Decontamination; Digestive System; Elective Surgical Procedures; Humans; Perioperative Care; Tobramycin | 2014 |
Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Child; Colistin; Cross-Over Studies; Cystic Fibrosis; Equipment Contamination; Equipment Design; Europe; Female; Forced Expiratory Volume; Humans; Lung; Male; Nebulizers and Vaporizers; Patient Satisfaction; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Time Factors; Tobramycin; Treatment Outcome; Young Adult | 2017 |
Prevention of severe infectious complications after colorectal surgery using preoperative orally administered antibiotic prophylaxis (PreCaution): study protocol for a randomized controlled trial.
Topics: Administration, Oral; Anti-Bacterial Agents; Antibiotic Prophylaxis; Colectomy; Colistin; Colon; Digestive System Surgical Procedures; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Incidence; Male; Netherlands; Randomized Controlled Trials as Topic; Rectum; Risk Factors; Surgical Wound Infection; Time Factors; Tobramycin; Treatment Outcome | 2018 |
Comparison of two therapeutic approaches for the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter: a randomized clinical trial study.
Topics: Acinetobacter; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Tobramycin | 2020 |
Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: results of a multicenter randomized placebo-controlled clinical trial.
Topics: Administration, Oral; Aged; Antibiotic Prophylaxis; Colistin; Colorectal Surgery; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Netherlands; Surgical Wound Infection; Therapeutic Equipoise; Tobramycin | 2020 |
Comparing inhaled colistin with inhaled fosfomycin/tobramycin as an adjunctive treatment for ventilator-associated pneumonia: An open-label randomized controlled trial.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Colistin; Fosfomycin; Humans; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Tobramycin; Treatment Outcome | 2023 |
135 other study(ies) available for tobramycin and colistin
| Article | Year |
|---|---|
Chemotherapy of chronic infections with mucoid Pseudomonas aeruginosa in lower airways of patients with cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Carbenicillin; Child; Child, Preschool; Chronic Disease; Colistin; Cystic Fibrosis; Drug Evaluation; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant; Male; Pneumonia; Precipitins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1979 |
Activity of gentamicin, tobramycin, polymyxin B, and colistimethate in mouse protection tests with Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Colistin; Gentamicins; Mice; Microbial Sensitivity Tests; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1975 |
Inter- and intralaboratory variability in antibiotic susceptibility tests with Pseudomonas aeruginosa and Enterobacteriaceae.
Topics: Carbenicillin; Colistin; Enterobacteriaceae; Escherichia coli; Gentamicins; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxins; Proteus; Pseudomonas aeruginosa; Quality Control; Species Specificity; Tobramycin | 1976 |
In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
Topics: Amikacin; Aminoglycosides; Ampicillin; Carbenicillin; Cephalothin; Child; Colistin; Cystic Fibrosis; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pseudomonas; Sputum; Tobramycin | 1979 |
Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
Topics: Anti-Bacterial Agents; Carbenicillin; Colistin; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Tobramycin | 1976 |
Antibiotic sensitivity of two Aeromonas and nine Pseudomonas species.
Topics: Aeromonas; Ampicillin; Carbenicillin; Cephalothin; Colistin; Gentamicins; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas; Sulfisomidine; Tetracycline; Tobramycin | 1975 |
Selective decontamination of the digestive tract contributes to the control of disseminated intravascular coagulation in severe liver impairment.
Topics: Administration, Oral; Cefuroxime; Colistin; Coxsackievirus Infections; Disseminated Intravascular Coagulation; Enterovirus B, Human; Gram-Negative Bacteria; Hepatitis, Viral, Human; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intestines; Tobramycin | 1992 |
Selective decontamination of the digestive tract prevents secondary infection of the abdominal cavity, and endotoxemia and mortality in sterile peritonitis in laboratory rats.
Topics: Animals; Anti-Bacterial Agents; Colistin; Digestive System; Endotoxins; Feces; Gram-Negative Bacteria; Gram-Positive Bacteria; Peritonitis; Rats; Tobramycin; Zymosan | 1992 |
Selective decontamination of the gastrointestinal tract as an infection control measure.
Topics: Amphotericin B; Colistin; Cross Infection; Disease Outbreaks; Gastrointestinal Diseases; Hospitals, Teaching; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tobramycin | 1991 |
Closure of a tracheoesophageal fistula by bronchoscopic application of fibrin glue and decontamination of the oral cavity.
Topics: Administration, Topical; Adult; Amphotericin B; Bacteria; Bronchoscopy; Colistin; Drug Therapy, Combination; Fibrin Tissue Adhesive; Humans; Male; Mouth; Tobramycin; Tracheoesophageal Fistula | 1991 |
[Frequency of colonization and pneumonia and development of resistance in long-term ventilated intensive-care patients subjected to selective decontamination of the digestive tract].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Bacteria; Cefotaxime; Colistin; Critical Care; Digestive System; Female; Humans; Male; Middle Aged; Oropharynx; Pneumonia; Respiration, Artificial; Time Factors; Tobramycin | 1989 |
Investigation of the immune status of mice during and following selective decontamination of the digestive tract.
Topics: Amphotericin B; Animals; Antibody Formation; Bacitracin; Cefotaxime; Colistin; Digestive System; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Hypersensitivity, Delayed; Immunity, Cellular; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Random Allocation; Streptomycin; Tobramycin | 1989 |
Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal.
Topics: Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Colistin; Digestive System; Dose-Response Relationship, Drug; Feces; Humans; Nalidixic Acid; Neomycin; Norfloxacin; Pipemidic Acid; Quinolines; Tobramycin | 1985 |
Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas.
Topics: Azlocillin; Ceftazidime; Colistin; Drug Synergism; Imipenem; Microbial Sensitivity Tests; Penicillin Resistance; Piperacillin; Pseudomonas; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 1987 |
Cefotaxime combined with selective decontamination in long term intensive care unit patients. Virtual absence of emergence of resistance.
Topics: Administration, Oral; Bacterial Infections; Cefotaxime; Colistin; Critical Care; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Infusions, Intravenous; Male; Time Factors; Tobramycin | 1988 |
Preventing lower airway colonization and infection in mechanically ventilated patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Colistin; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Pneumonia; Prospective Studies; Respiration, Artificial; Respiratory System; Respiratory Tract Infections; Tobramycin | 1987 |
Determination of antimicrobial susceptibility of Pseudomonas aeruginosa by disk diffusion and microdilution methods.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Colistin; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1980 |
[Pseudomonas endocarditis on aortic valve prosthesis. Successful treatment by association of tobramycin-rifampicin-colistin and two reinterventions. Follow-up of 5 years (author's transl)].
Topics: Adult; Aortic Valve; Colistin; Drug Therapy, Combination; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Male; Postoperative Complications; Pseudomonas Infections; Rifampin; Tobramycin | 1981 |
Guidelines for adequate chemotherapeutic dosage in newborns and infants with septicaemia and meningitis.
Topics: Amikacin; Anti-Bacterial Agents; Cefuroxime; Colistin; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Meningitis; Sepsis; Tobramycin | 1980 |
Postoperative selective bowel decontamination prevents gram-negative bacterial translocation in small-bowel graft recipients.
Topics: Animals; Cell Movement; Colistin; Colony Count, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Intestine, Small; Liver; Lymph Nodes; Mesentery; Postoperative Care; Rats; Rats, Inbred Lew; Spleen; Tacrolimus; Tobramycin | 1995 |
Pathogenesis and prevention of early pancreatic infection in experimental acute necrotizing pancreatitis.
Topics: Acute Disease; Administration, Oral; Amphotericin B; Animals; Bacteria; Bacterial Infections; Bacterial Physiological Phenomena; Cecal Diseases; Cefotaxime; Colistin; Disease Models, Animal; Drug Therapy, Combination; Imipenem; Injections, Intravenous; Kidney Diseases; Male; Necrosis; Pancreas; Pancreatic Diseases; Pancreatitis; Rats; Rats, Sprague-Dawley; Survival Rate; Tobramycin | 1995 |
Nebulizer performance: AFLM study. Association Française de Lutte contre la Mucoviscidose.
Topics: Administration, Inhalation; Aerosols; Amiloride; Colistin; Cystic Fibrosis; Humans; Nebulizers and Vaporizers; Tobramycin | 1995 |
[Characterization by isotope method of the performance of the pneumatic nebulizer NL9 Atomizer in the production of colistin, tobramycin and amiloride aerosols].
Topics: Aerosols; Amiloride; Colistin; Cystic Fibrosis; Evaluation Studies as Topic; Humans; Nebulizers and Vaporizers; Particle Size; Sodium Pertechnetate Tc 99m; Surface Tension; Tobramycin | 1994 |
Nosocomial infection in a neonatal intensive care unit and its prevention with selective intestinal decolonization. A multivariant evaluation of infection reduction.
Topics: Chi-Square Distribution; Cohort Studies; Colistin; Confounding Factors, Epidemiologic; Cross Infection; Drug Therapy, Combination; Humans; Incidence; Infant, Newborn; Intensive Care Units, Neonatal; Intestines; Logistic Models; Multivariate Analysis; Nystatin; Prospective Studies; Spain; Tobramycin | 1994 |
Enteric bacterial overgrowth and translocation in a swine model of small bowel transplantation.
Topics: Animals; Bacteria, Aerobic; Bacterial Infections; Colistin; Drug Therapy, Combination; Enterobacteriaceae; Female; Intestine, Small; Liver; Liver Transplantation; Lung; Lymph Nodes; Mycoses; Nystatin; Postoperative Complications; Spleen; Swine; Tobramycin; Transplantation, Autologous; Vancomycin | 1994 |
Interaction of sucralfate with antibiotics used for selective decontamination of the gastrointestinal tract.
Topics: Amphotericin B; Anti-Bacterial Agents; Colistin; Digestive System; Drug Incompatibility; Drug Interactions; Drug Stability; Humans; Sucralfate; Tobramycin | 1993 |
Selective decontamination of the digestive tract (SDD) does not prevent the formation of microbial biofilms on endotracheal tubes.
Topics: Amphotericin B; Bacteria; Bacterial Adhesion; Bacterial Infections; Colistin; Critical Care; Digestive System; Humans; Intubation, Intratracheal; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus aureus; Tobramycin; Trachea | 1993 |
Epidemiological impact of prolonged systematic use of topical SDD on bacterial colonization of the tracheobronchial tree and antibiotic resistance. A three year study.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Bronchi; Colistin; Colony Count, Microbial; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Incidence; Infection Control; Intensive Care Units; Intubation, Gastrointestinal; Pneumonia; Respiration, Artificial; Sputum; Tobramycin; Trachea | 1993 |
[Comparative study of the performance and ergonomics of nebulizers in cystic fibrosis].
Topics: Administration, Inhalation; Adult; Aerosols; Amiloride; Anti-Bacterial Agents; Child; Colistin; Cystic Fibrosis; Diuretics; Equipment Design; Ergonomics; Humans; Materials Testing; Nebulizers and Vaporizers; Particle Size; Tobramycin | 1996 |
Parenteral fluoroquinolones prevent translocation of enterobacteria following combined liver-small bowel transplantation in pigs.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Translocation; Cefazolin; Colistin; Enterobacteriaceae; Female; Fluoroquinolones; Immunosuppression Therapy; Injections, Intramuscular; Intestinal Mucosa; Intestine, Small; Liver; Liver Transplantation; Lung; Lymph Nodes; Pefloxacin; Quinolones; Spleen; Swine; Tobramycin; Transplantation, Homologous | 1996 |
Influence of different protocols of antibiotic prophylaxis on endoluminal bacterial overgrowth and translocation following small-bowel or combined liver-small-bowel transplantation in a large-animal model.
Topics: Animals; Antibiotic Prophylaxis; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Cefazolin; Colistin; Cyclosporine; Drug Therapy, Combination; Enterobacteriaceae; Female; Intestine, Small; Liver; Liver Transplantation; Lung; Lymph Nodes; Nystatin; Spleen; Swine; Tobramycin; Transplantation, Homologous; Vancomycin | 1997 |
Influence of selective decontamination of the digestive tract on cell-mediated immune function and bacteria/endotoxin translocation in thermally injured rats.
Topics: Animals; Anti-Bacterial Agents; Bacterial Translocation; Burns; Cell Division; Cells, Cultured; Colistin; Digestive System; Disease Models, Animal; Endotoxins; Flucytosine; Immunity, Cellular; Immunosuppression Therapy; Interleukin-2; Intestines; Lymphocyte Subsets; Rats; Rats, Sprague-Dawley; Spleen; Tobramycin | 1997 |
Microbial translocation and impairment of mucosal immunity induced by an elemental diet in rats is prevented by selective decontamination of the digestive tract.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacterial Translocation; Colistin; Culture Techniques; Digestive System; Disease Models, Animal; Female; Food, Formulated; Fungi; Gram-Negative Bacteria; Intestinal Mucosa; Parenteral Nutrition, Total; Probability; Rats; Rats, Inbred Strains; Tobramycin | 1998 |
Topical antibiotics on tracheostoma prevents exogenous colonization and infection of lower airways in children.
Topics: Administration, Topical; Adolescent; Antibiotic Prophylaxis; Bacteriological Techniques; Child; Child, Preschool; Cohort Studies; Colistin; Cross Infection; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Male; Oropharynx; Pilot Projects; Pneumonia, Bacterial; Prospective Studies; Tobramycin; Tracheostomy; Treatment Outcome | 2000 |
Antimicrobial resistance in enteric porcine Escherichia coli strains in Spain.
Topics: Amoxicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Cephalosporins; Colistin; Diarrhea; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Nebramycin; Neomycin; Quinolones; Spain; Swine; Swine Diseases | 2000 |
Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization.
Topics: Administration, Inhalation; Administration, Oral; Ceftazidime; Child; Child, Preschool; Chronic Disease; Colistin; Colony Count, Microbial; Cystic Fibrosis; DNA, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Imipenem; Infant; Male; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Assessment; Tobramycin | 2001 |
Short-term effect of the application of selective decontamination of the digestive tract on different body site reservoir ICU patients colonized by multi-resistant Acinetobacter baumannii.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Colistin; Digestive System; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Pilot Projects; Prospective Studies; Tobramycin | 2002 |
In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany.
Topics: Aerosols; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Drug Evaluation, Preclinical; Germany; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 2002 |
Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Ciprofloxacin; Clinical Trials as Topic; Colistin; Cystic Fibrosis; Humans; Pseudomonas Infections; Tobramycin | 2002 |
Colistin stimulates the activity of neutrophil elastase and Pseudomonas aeruginosa elastase.
Topics: Adolescent; Adult; alpha 1-Antitrypsin; Amino Acid Chloromethyl Ketones; Anti-Bacterial Agents; Anticoagulants; Bacterial Proteins; Ceftazidime; Child; Colistin; Cystic Fibrosis; Enzyme Activation; Erythromycin; Female; Gentamicins; Heparin; Humans; In Vitro Techniques; Leukocyte Elastase; Male; Metalloendopeptidases; Respiratory Tract Infections; Serine Proteinase Inhibitors; Sputum; Tobramycin | 2002 |
Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Resistance, Bacterial; Gentamicins; Humans; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2003 |
New clinical evidence from the European tobramycin trial in cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Europe; Humans; Lung Diseases; Nebulizers and Vaporizers; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Function Tests; Tobramycin; Treatment Outcome | 2002 |
Insights into cystic fibrosis microbiology from the European tobramycin trial in cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Biofilms; Colistin; Cystic Fibrosis; Europe; Humans; Lung Diseases; Microbial Sensitivity Tests; Nebulizers and Vaporizers; Pseudomonas Infections; Randomized Controlled Trials as Topic; Tobramycin | 2002 |
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin; Tobramycin | 2004 |
Molecular and phenotypic features for identification of the opportunistic pathogens Ochrobactrum spp.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactams; Colistin; Culture Media; DNA, Bacterial; DNA, Ribosomal; Fermentation; Gentian Violet; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Netilmicin; Ochrobactrum; Opportunistic Infections; Oxidoreductases; Phenazines; Ribotyping; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Temperature; Tobramycin; Urease | 2005 |
Evaluation of MRSA Select, a new chromogenic medium for the detection of nasal carriage of methicillin-resistant Staphylococcus aureus.
Topics: Amphotericin B; Colistin; Culture Media; Humans; Methicillin Resistance; Nasal Mucosa; Oxacillin; Sensitivity and Specificity; Staphylococcus aureus; Tobramycin | 2006 |
Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftazidime; Colistin; Dose-Response Relationship, Drug; Drug Synergism; In Vitro Techniques; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Mutation; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 2006 |
Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
Topics: Acetylglucosaminidase; Adolescent; Adult; Anti-Bacterial Agents; Colistin; Creatinine; Cystic Fibrosis; Diabetes Mellitus; Female; Humans; Kidney Tubules; Kidney Tubules, Proximal; Male; Prospective Studies; Tobramycin | 2007 |
Effects of long-term routine use of selective digestive decontamination on antimicrobial resistance.
Topics: Amphotericin B; Anti-Bacterial Agents; Colistin; Cross Infection; Digestive System; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Methicillin Resistance; Microbial Sensitivity Tests; Patient Isolation; Population Surveillance; Prospective Studies; Tobramycin | 2006 |
The incidence and microbial spectrum of ventilator-associated pneumonia after tracheotomy in a selective decontamination of the digestive tract-setting.
Topics: Administration, Buccal; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antibiotic Prophylaxis; Colistin; Critical Illness; Cross Infection; Decontamination; Enteral Nutrition; Female; Gastrointestinal Tract; Humans; Incidence; Intensive Care Units; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Netherlands; Pneumonia, Ventilator-Associated; Retrospective Studies; Risk Factors; Staphylococcus aureus; Tobramycin; Tracheotomy | 2008 |
Shifting patterns of inhaled antibiotic use in cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Colistin; Cystic Fibrosis; Drug Utilization; Female; Humans; Male; Respiratory Tract Infections; Tobramycin | 2008 |
[Aminoglycosides and colistin inhibit biofilm formation in Klebsiella pneumoniae].
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Catheterization; Colistin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tobramycin | 2008 |
Near InfraRed Spectroscopy homogeneity evaluation of complex powder blends in a small-scale pharmaceutical preformulation process, a real-life application.
Topics: Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Colistin; Drug Compounding; Equipment Design; Light; Particle Size; Pharmaceutical Preparations; Powders; Scattering, Radiation; Software; Spectroscopy, Near-Infrared; Technology, Pharmaceutical; Tobramycin | 2009 |
Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Cohort Studies; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Kaplan-Meier Estimate; Middle Aged; Retrospective Studies; Tobramycin; Treatment Outcome | 2009 |
Simultaneous quantitation of tobramycin and colistin sulphate by HPLC with evaporative light scattering detection.
Topics: Chromatography, High Pressure Liquid; Colistin; Light; Reference Standards; Reproducibility of Results; Scattering, Radiation; Sensitivity and Specificity; Tobramycin | 2009 |
Implementation of European standards of care for cystic fibrosis--control and treatment of infection.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Bacterial Infections; Burkholderia cepacia; Burkholderia Infections; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Europe; Guideline Adherence; Humans; Infection Control; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Surveys and Questionnaires; Tobramycin; Young Adult | 2009 |
The costs of treatment of early and chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Child, Preschool; Chronic Disease; Ciprofloxacin; Clavulanic Acids; Colistin; Cost of Illness; Cystic Fibrosis; Humans; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins; Ticarcillin; Tobramycin | 2009 |
Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Adult; Aerosols; Amikacin; Anti-Bacterial Agents; APACHE; Colistin; Critical Illness; Drug Resistance, Multiple; Female; Glasgow Coma Scale; Gram-Negative Bacteria; Humans; Male; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Retrospective Studies; Tobramycin; Treatment Outcome | 2009 |
Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteria; Biofilms; Calcium Chloride; Chlorides; Colistin; Drug Resistance, Bacterial; Drug Resistance, Multiple; Drug Synergism; Enterococcus faecium; Erythrocytes; Escherichia coli; Humans; Imidazoles; Magnesium; Manganese Compounds; Methicillin-Resistant Staphylococcus aureus; Novobiocin; Staphylococcus epidermidis; Tobramycin; Triazoles | 2010 |
A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
Topics: Anti-Bacterial Agents; Bacteremia; Bile Duct Diseases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2010 |
In vitro inhibition of neutrophil elastase activity by inhaled anti-Pseudomonas antibiotics used in cystic fibrosis patients.
Topics: Administration, Inhalation; Albumins; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Humans; Leukocyte Elastase; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas Infections; Tobramycin | 2010 |
Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment.
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; Chronic Disease; Cluster Analysis; Colistin; Cystic Fibrosis; DNA Fingerprinting; Drug Resistance, Bacterial; Female; Genotype; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2010 |
Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis.
Topics: Administration, Inhalation; Ambulatory Care; Anti-Bacterial Agents; Bronchitis, Chronic; Colistin; Cystic Fibrosis; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2011 |
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Burkholderia cepacia complex; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Colistin; Cystic Fibrosis; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Health Care Costs; Health Resources; Humans; Infant; Injections, Intravenous; Nebulizers and Vaporizers; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2011 |
Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Cerebral Ventriculitis; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Rifampin; Tobramycin; Treatment Outcome; Vancomycin | 2011 |
Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Colistin; Deoxyribonucleases; DNA, Bacterial; Extracellular Matrix; Extracellular Space; Fluorescence; Humans; Microbial Sensitivity Tests; Mutation; Phagocytes; Phenotype; Pseudomonas aeruginosa; Surface Properties; Time Factors; Tobramycin | 2011 |
In vitro activities of the novel ceragenin CSA-13, alone or in combination with colistin, tobramycin, and ciprofloxacin, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
Topics: Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Steroids; Tobramycin | 2011 |
Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Inhalation; Aerosols; Anti-Bacterial Agents; APACHE; Bronchoalveolar Lavage; Colistin; Comorbidity; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Statistics, Nonparametric; Survival Rate; Tobramycin; Treatment Outcome | 2012 |
Long-term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Female; Gentamicins; Humans; Infusions, Intravenous; Kidney; Male; Retrospective Studies; Time; Tobramycin | 2012 |
Aerosolized antibiotic therapy: a forward aerial assault or forced contingency for ventilator-associated pneumonia?
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Female; Humans; Male; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas Infections; Tobramycin | 2012 |
Mutant prevention concentration of colistin alone and in combination with levofloxacin or tobramycin against multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Colistin; Drug Interactions; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Selection, Genetic; Tobramycin | 2012 |
Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Colistin; Cross Infection; Decontamination; Disease Outbreaks; Drug Resistance, Bacterial; Gastrointestinal Tract; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies; Tobramycin | 2013 |
Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Typing Techniques; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Iran; Microbial Sensitivity Tests; Minocycline; Multiplex Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Rifampin; Sulbactam; Tertiary Healthcare; Tigecycline; Tobramycin | 2013 |
Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Ceftazidime; Colistin; Drug Resistance, Bacterial; Drug Synergism; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tobramycin | 2013 |
The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Colistin; Down-Regulation; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Multigene Family; Pseudomonas aeruginosa; Tobramycin | 2013 |
Physicochemical compatibility of nebulizable drug admixtures containing colistimethate and tobramycin.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Colistin; Drug Combinations; Drug Incompatibility; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nebulizers and Vaporizers; Osmolar Concentration; Pharmaceutical Solutions; Pseudomonas aeruginosa; Tobramycin | 2013 |
The cost effectiveness of dry powder antibiotics for the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Colistin; Cost-Benefit Analysis; Cystic Fibrosis; Decision Support Techniques; Dry Powder Inhalers; Humans; Models, Economic; Pneumonia, Bacterial; Probability; Pseudomonas aeruginosa; Pseudomonas Infections; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Survival Analysis; Tobramycin; Young Adult | 2014 |
Colistin resistance during selective digestive tract decontamination is uncommon.
Topics: Colistin; Drug Resistance, Bacterial; Gastrointestinal Tract; Humans; Klebsiella pneumoniae; Tobramycin | 2014 |
Reply to "colistin resistance during selective digestive tract decontamination is uncommon".
Topics: Colistin; Drug Resistance, Bacterial; Gastrointestinal Tract; Humans; Klebsiella pneumoniae; Tobramycin | 2014 |
NICE guidance on colistimethate sodium and tobramycin for pseudomonas lung infection in cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Clinical Trials as Topic; Colistin; Cystic Fibrosis; Drug Monitoring; Drug Therapy, Combination; Dry Powder Inhalers; Humans; Practice Guidelines as Topic; Pseudomonas Infections; Respiratory Function Tests; Respiratory Tract Infections; State Medicine; Tobramycin; United Kingdom | 2013 |
Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin; Treatment Failure | 2014 |
Selective digestive tract decontamination and spread of colistin resistance: antibiotic prophylaxis is not a substitute for hygiene.
Topics: Colistin; Drug Resistance, Bacterial; Gastrointestinal Tract; Humans; Klebsiella pneumoniae; Tobramycin | 2014 |
Reply to "selective digestive tract decontamination and spread of colistin resistance: antibiotic prophylaxis is not a substitute for hygiene".
Topics: Colistin; Drug Resistance, Bacterial; Gastrointestinal Tract; Humans; Klebsiella pneumoniae; Tobramycin | 2014 |
Systemic absorption of nasally administered tobramycin and colistin in patients with cystic fibrosis.
Topics: Absorption, Physiological; Administration, Intranasal; Adult; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Female; Humans; Male; Nasal Mucosa; Tobramycin; Young Adult | 2014 |
Successful treatment of extensively drug-resistant Pseudomonas aeruginosa osteomyelitis using a colistin- and tobramycin-impregnated PMMA spacer.
Topics: Anti-Bacterial Agents; Colistin; Drug Carriers; Drug Resistance, Multiple, Bacterial; Humans; Male; Middle Aged; Osteomyelitis; Plasma; Polymethyl Methacrylate; Pseudomonas aeruginosa; Pseudomonas Infections; Synovial Fluid; Tobramycin; Treatment Outcome | 2014 |
Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.
Topics: Anti-Bacterial Agents; Cell Line; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Meropenem; Microbial Sensitivity Tests; Monocytes; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin | 2015 |
Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled antibiotic classes.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Anti-Bacterial Agents; Aztreonam; Child; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tobramycin; Treatment Outcome; Young Adult | 2015 |
Effects of various antibiotics alone or in combination with doripenem against Klebsiella pneumoniae strains isolated in an intensive care unit.
Topics: Carbapenems; Colistin; Doripenem; Dose-Response Relationship, Drug; Drug Combinations; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Minocycline; Rifampin; Tigecycline; Tobramycin | 2014 |
A demonstration of the susceptibility of clinical isolates obtained from cystic fibrosis patients to manuka honey.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Burkholderia; Burkholderia Infections; Colistin; Cystic Fibrosis; Honey; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2015 |
Selective decontamination of the digestive tract ameliorates severe burn-induced insulin resistance in rats.
Topics: Animals; Anti-Infective Agents; Blotting, Western; Burns; Colistin; Cytokines; Flucytosine; Gastrointestinal Microbiome; Gastrointestinal Tract; Glucose Tolerance Test; I-kappa B Kinase; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipopolysaccharides; Male; MAP Kinase Kinase 4; Permeability; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Tobramycin | 2015 |
Purity determination of amphotericin B, colistin sulfate and tobramycin sulfate in a hydrophilic suspension by HPLC.
Topics: Amphotericin B; Chromatography, High Pressure Liquid; Colistin; Drug Contamination; Drug Stability; Hydrophobic and Hydrophilic Interactions; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Suspensions; Tobramycin | 2015 |
Colistin and tobramycin resistance during long- term use of selective decontamination strategies in the intensive care unit: a post hoc analysis.
Topics: Anti-Bacterial Agents; Colistin; Decontamination; Drug Resistance, Bacterial; Gastrointestinal Tract; Gram-Negative Bacteria; Humans; Intensive Care Units; Oropharynx; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Tobramycin | 2015 |
In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa.
Topics: Animals; Anti-Infective Agents; Biofilms; Cell Line, Tumor; Colistin; Cystic Fibrosis; Disease Models, Animal; Female; Lung Diseases; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2015 |
Precautionary Practices of Respiratory Therapists and Other Health-Care Practitioners Who Administer Aerosolized Medications.
Topics: Adult; Aerosols; Amikacin; Anti-Infective Agents; Colistin; Female; Guideline Adherence; Health Personnel; Humans; Male; Middle Aged; National Institute for Occupational Safety and Health, U.S.; Occupational Exposure; Occupational Health; Pentamidine; Respiratory Therapy; Surveys and Questionnaires; Tobramycin; United States | 2015 |
Mucin Binding Reduces Colistin Antimicrobial Activity.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Culture Media; Daptomycin; Dialysis; Dialysis Solutions; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mucins; Polymyxin B; Protein Binding; Pseudomonas aeruginosa; Staphylococcus aureus; Swine; Tobramycin | 2015 |
Effect of High-Dose Antimicrobials on Biofilm Growth of Achromobacter Species Isolated from Cystic Fibrosis Patients.
Topics: Achromobacter; Amikacin; Anti-Bacterial Agents; Aztreonam; Biofilms; Colistin; Cystic Fibrosis; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Plankton; Tobramycin | 2016 |
Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
Topics: Amides; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Lung; Microscopy, Confocal; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrimidines; Quorum Sensing; Respiratory Tract Infections; Tobramycin | 2015 |
Sequential Inhalational Tobramycin-Colistin-Combination in CF-Patients with Chronic P. Aeruginosa Colonization - an Observational Study.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Chronic Disease; Colistin; Cystic Fibrosis; Drug Administration Schedule; Drug Combinations; Female; Forced Expiratory Volume; Humans; Male; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2016 |
Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Iran; Microbial Sensitivity Tests; Minocycline; Sulbactam; Tigecycline; Tobramycin | 2016 |
In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Colistin; Culture Media; Disease Models, Animal; Drug Administration Schedule; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tobramycin; Treatment Outcome | 2016 |
Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum.
Topics: A549 Cells; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Cattle; Cell Culture Techniques; Colistin; Drug Synergism; Fetus; Gentamicins; Humans; Lung; Microbial Sensitivity Tests; Models, Biological; Oligopeptides; Pseudomonas aeruginosa; Serum; Tight Junctions; Tobramycin | 2017 |
Highly Potent Antibacterial Organometallic Peptide Conjugates.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cell Membrane; Colistin; Drug Synergism; Membrane Proteins; Metals, Heavy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Organometallic Compounds; Pseudomonas aeruginosa; Solid-Phase Synthesis Techniques; Tobramycin | 2017 |
Susceptibility of Pseudomonas aeruginosa Dispersed Cells to Antimicrobial Agents Is Dependent on the Dispersion Cue and Class of the Antimicrobial Agent Used.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Colistin; Cyclic GMP; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Glutamic Acid; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 2017 |
Oral Tobramycin Prophylaxis Prior to Colorectal Surgery Is Not Associated with Systemic Uptake.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Colistin; Colorectal Surgery; Female; Humans; Male; Middle Aged; Prospective Studies; Surgical Wound Infection; Tobramycin | 2018 |
Dynamics of colistin and tobramycin resistance among
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Intensive Care Units; Microbial Sensitivity Tests; Polymorphism, Single Nucleotide; Prospective Studies; Retrospective Studies; Tobramycin; Whole Genome Sequencing | 2018 |
Long-term use of selective digestive decontamination in an ICU highly endemic for bacterial resistance.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cohort Studies; Colistin; Decontamination; Drug Resistance, Bacterial; Female; Gastrointestinal Tract; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Protective Factors; Spain; Tobramycin | 2018 |
Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin.
Topics: Anti-Bacterial Agents; Biofilms; Colistin; Humans; Microbial Sensitivity Tests; Mucus; Pseudomonas aeruginosa; Tobramycin; Trachea | 2018 |
Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Colistin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Phages; Tobramycin | 2018 |
Preoperative Oral Antibiotic Prophylaxis Reduces Surgical Site Infections After Elective Colorectal Surgery: Results From a Before-After Study.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Colistin; Colorectal Surgery; Controlled Before-After Studies; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Netherlands; Preoperative Care; Retrospective Studies; Surgical Wound Infection; Tobramycin | 2019 |
Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing
Topics: Animals; Anti-Bacterial Agents; Biofilms; Colistin; Colonic Neoplasms; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Drug Dosage Calculations; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2018 |
Role of Viscoelasticity in Bacterial Killing by Antimicrobials in Differently Grown
Topics: Anti-Bacterial Agents; Biofilms; Colistin; Culture Media; Extracellular Matrix; Microbial Sensitivity Tests; Mucins; Pseudomonas aeruginosa; Tobramycin; Viscosity | 2019 |
Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis.
Topics: Administration, Inhalation; Administration, Intravenous; Adult; Anti-Bacterial Agents; Azithromycin; Colistin; Cystic Fibrosis; Disease Progression; Female; Forced Expiratory Volume; Humans; Logistic Models; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tobramycin; Young Adult | 2019 |
Antibiotic efficacy varies based on the infection model and treatment regimen for
Topics: Animals; Anti-Bacterial Agents; Colistin; Humans; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2020 |
Nanodiagnostics to monitor biofilm oxygen metabolism for antibiotic susceptibility testing.
Topics: Anti-Bacterial Agents; Biofilms; Colistin; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Nanoparticles; Oxygen; Porphyrins; Pseudomonas aeruginosa; Pyridinium Compounds; Styrenes; Tobramycin | 2020 |
Evaluation of the synergy of ceftazidime/avibactam in combination with colistin, doripenem, levofloxacin, tigecycline, and tobramycin against OXA-48 producing Enterobacterales.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Ceftazidime; Colistin; Doripenem; Drug Combinations; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Tigecycline; Tobramycin | 2020 |
Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Furans; Gallium; Humans; Meropenem; Microbial Sensitivity Tests; Protein Biosynthesis; Pseudomonas aeruginosa; Quorum Sensing; Tobramycin; Virulence | 2020 |
Incidence of nephrotoxicity with prolonged aminoglycoside exposure in patients with cystic fibrosis.
Topics: Acute Kidney Injury; Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Child; Child, Preschool; Colistin; Cystic Fibrosis; Female; Humans; Incidence; Infant; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Retrospective Studies; Risk Factors; Tobramycin; Vancomycin; Young Adult | 2020 |
Does the mode of dispersion determine the properties of dispersed Pseudomonas aeruginosa biofilm cells?
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Biofilms; Colistin; Cyclic GMP; Drug Resistance, Bacterial; Humans; Moths; Pseudomonas aeruginosa; Tobramycin | 2020 |
Efficacy of EBL-1003 (apramycin) against Acinetobacter baumannii lung infections in mice.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Animals; Anti-Bacterial Agents; Colistin; Lung; Mice; Microbial Sensitivity Tests; Nebramycin | 2021 |
Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cell Survival; Colistin; Cystic Fibrosis; Drug Combinations; Humans; Ibuprofen; Inflammation; Interleukin-8; Lipopolysaccharides; Pseudomonas aeruginosa; Tobramycin | 2021 |
Efficacy of Problem-Solving Intervention to Improve Adherence in Adolescents and Adults with Cystic Fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Body Mass Index; Colistin; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Male; Medication Adherence; Patient-Centered Care; Problem Solving; Quality of Life; Tobramycin; Young Adult | 2021 |
Antimicrobial effects of Melaleuca alternifolia (tea tree) essential oil against biofilm-forming multidrug-resistant cystic fibrosis-associated Pseudomonas aeruginosa as a single agent and in combination with commonly nebulized antibiotics.
Topics: Anti-Bacterial Agents; Aztreonam; Biofilms; Colistin; Cystic Fibrosis; Melaleuca; Microbial Sensitivity Tests; Oils, Volatile; Pseudomonas aeruginosa; Tea; Tea Tree Oil; Tobramycin; Trees | 2022 |
Seaweed Extracts: A Promising Source of Antibiofilm Agents with Distinct Mechanisms of Action against
Topics: Anti-Bacterial Agents; Biofilms; Colistin; Drug Synergism; Gas Chromatography-Mass Spectrometry; Phaeophyceae; Pseudomonas aeruginosa; Rhodophyta; Solvents; Tobramycin; Ulva | 2022 |
Acute kidney injury in cystic fibrosis patients treated with intravenous colistimethate sodium or tobramycin.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin | 2022 |
Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Deoxyribonucleases; Drug Resistance, Bacterial; Genotype; Gentamicins; Humans; Imipenem; Iran; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Pancreatic Elastase; Phospholipases; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence Factors | 2022 |
Time kill-assays of antibiotic combinations for multidrug resistant clinical isolates of OXA-48 carbapenemase producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Colistin; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Tobramycin | 2022 |
Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin.
Topics: Administration, Inhalation; Aerosols; Colistin; Dry Powder Inhalers; Particle Size; Powders; Spray Drying; Tobramycin | 2022 |
Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Asia, Southeastern; Blood Culture; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nebramycin; Pseudomonas aeruginosa; Tobramycin | 2022 |
In vitro models to detect in vivo bile acid changes induced by antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Caco-2 Cells; Colistin; Doripenem; Humans; Meropenem; Rats; RNA, Ribosomal, 16S; Taurocholic Acid; Tobramycin | 2022 |
The Effects of Antibiotic Combination Treatments on Pseudomonas aeruginosa Tolerance Evolution and Coexistence with Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Stenotrophomonas maltophilia; Tobramycin | 2022 |
Connecting Gut Microbial Diversity with Plasma Metabolome and Fecal Bile Acid Changes Induced by the Antibiotics Tobramycin and Colistin Sulfate.
Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Colistin; Feces; Gastrointestinal Microbiome; Metabolome; Rats; Rats, Wistar; RNA, Ribosomal, 16S; Tobramycin | 2023 |
Chronic inhaled antibiotic therapy in people with cystic fibrosis with Pseudomonas aeruginosa infection in Germany.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Child; Colistin; Cystic Fibrosis; Germany; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tobramycin | 2023 |
Sputum culture and antibiotic resistance in elderly inpatients with exacerbation of chronic obstructive pulmonary disease at a tertiary geriatric hospital in southern Vietnam.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gentamicins; Hospitals; Humans; Inpatients; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Pulmonary Disease, Chronic Obstructive; Sputum; Teicoplanin; Tobramycin; Vancomycin; Vietnam | 2023 |
Genomics of Aminoglycoside Resistance in Pseudomonas aeruginosa Bloodstream Infections at a United States Academic Hospital.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Genomics; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tobramycin; United States | 2023 |
Efficacy of antibiotic combinations in an experimental sepsis model with Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Colistin; Fosfomycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Sepsis; Tobramycin | 2023 |